As of 2025-06-25, the Fair Value of Taysha Gene Therapies Inc (TSHA) is -1.56 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.37 USD, the upside of Taysha Gene Therapies Inc is -165.95%.
With the market price of 2.37 USD and our fair value calculation, Taysha Gene Therapies Inc (TSHA) is not a good investment. Investing in TSHA stocks now will result in a potential loss of 165.95%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -60.01 | -174.52 | -166.01 | -111.57 | -89.30 | -120.28 |
| YoY growth | -5,258.04% | -190.82% | 4.88% | 32.80% | 19.96% | -1,078.24% |
| Market Cap (mil) | 657.85 |
| P/E | |
| Forward P/E |
| EPS | -0.31 |
| Avg earnings growth rate | -1,078.24% |
| TTM earnings | -86.77 |